COGT
Cogent Biosciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
COGT Filings
Filing Date
Form Description
Form Type
2025-11-18
Form 8-K - Current report
Key Events
2025-11-18 · Key Events
Form 8-K - Current report
2025-11-17
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-17 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-13
Form 8-K - Current report
Key Events
2025-11-13 · Key Events
Form 8-K - Current report
2025-11-12
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-12 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-12
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-12 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
